Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPAACT 1092: Phase IV Evaluation Of The Steady State Pharmacokinetics Of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1-Infected Children

NCT01818258 is registered in ClinicalTrials.gov with International Maternal Pediatric Adolescent AIDS Clinical Trials Group as lead sponsor.

NCT NCT01818258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01818258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPAACT 1092: Phase IV Evaluation Of The Steady State Pharmacokinetics Of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1-Infected Children
Lead sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase
Phase 4
Overall status
Completed
Start date
October 26, 2015
Completion date
September 29, 2017
Enrollment
52 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv positive, malnourished